Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports

Reuters
Written By St. Paul Corner Drug (SPCD)

The Pharmaceutical Care Management Association (PCMA), a key lobbying group for pharmacy middlemen, is drafting recommendations to present to the Centers for Medicare and Medicaid Services, Bloomberg News reported, citing a reviewed document.

Read the article here
St. Paul Corner Drug (SPCD)
Previous

Tylenol Issues Clarification After White House Resurfaces 2017 Tweet on Usage During Pregnancy
Next

CVS’s Omnicare Files Bankruptcy After $949 Million Judgment